Dr. Gandhi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Fruit St
Infectious Disease
Boston, MA 02114Phone+1 617-726-8403Fax+1 617-726-7653- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Infectious Disease, 1998 - 1999
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1993 - 1996
- Brigham and Women's HospitalResidency, Internal Medicine, 1990 - 1993
- Harvard Medical SchoolClass of 1990
Certifications & Licensure
- MA State Medical License 1992 - 2025
- MD State Medical License 1999 - 2000
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load Start of enrollment: 2007 Nov 01
- A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects Start of enrollment: 2009 Aug 01
- Sevelamer for Reducing Endotoxemia and Immune Activation Start of enrollment: 2011 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsSelection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2a.Marie Armani-Tourret, Ce Gao, Ciputra Adijaya Hartana, WeiWei Sun, Leah Carrere, Liliana Vela, Alexander Hochroth, Maxime Bellefroid, Amy Sbrolla, Katrina Shea, Theres...> ;Cell. 2024 Feb 29
- COVID-19 Therapeutics for Nonhospitalized Patients-Updates and Future Directions.Kara W Chew, Preeti N Malani, Rajesh T Gandhi> ;JAMA. 2023 Oct 24
- 17 citationsTreatments for COVID-19.Hayden S Andrews, Jonathan D Herman, Rajesh T Gandhi> ;Annual Review of Medicine. 2024 Jan 29
- Join now to see all
Journal Articles
- The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Post-Treatment Controllers Identified from 14 Clinical StudiesElizabeth Connick, Michael C Sneller, Jonathan Z Li, Paul Volberding, Daniel R Kuritzkes, Robert T Schooley, David Margolis, Daniel Skiest, John W Mellors, Ronald Mits..., The Journal of Infectious Diseases
- Antiretrovirals and Pregnancy: New Warnings Demand Close AttentionRajesh Gandhi, MD, NEJM Journal Watch
Other
- Review Promises and Pitfalls in the Reconstitution of Immunity in Patients Who Have HIV-1 InfectionRajesh Gandhi, MD, ScienceDirect
https://www.doximity.com/articles/91313802-bb90-4952-9a06-f5981fb2ae80
UpToDate, Wolters Kluwer Health - 2012-11-05
Authored Content
- Review Promises and Pitfalls in the Reconstitution of Immunity in Patients Who Have HIV-1 InfectionAugust 2002
Press Mentions
- What Happens After COVID-19 Emergencies End?May 11th, 2023
- Paxlovid for COVID-19: What Seniors Need to KnowJanuary 18th, 2023
- What Seniors Need to Know About Taking PaxlovidJanuary 17th, 2023
- Join now to see all
Grant Support
- ClinicalNational Institute Of Allergy And Infectious Diseases2009–2011
- Induction Of Hiv-Specific Immune ResponsesNational Institute Of Allergy And Infectious Diseases2006–2010
- Emicrobes: A Digital Library For Learning Infectious DiseasesNational Library Of Medicine2007–2009
- Mechanisms Of T Cell Apoptosis During HIV1 InfectionNational Institute Of Allergy And Infectious Diseases2000–2002
- Mechanisms Of T Cell Apoptosis During HIV1 InfectionNational Institute Of Allergy And Infectious Diseases1999
- Mechanisms Of T Cell Apoptosis During HIV1 InfectionNational Institute Of Allergy And Infectious Diseases1997
Hospital Affiliations
- Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: